4 New Undervalued Stocks with 4-Star Ratings

Four US-listed stocks, Keurig Dr Pepper, Ball, Hormel Foods, and Qiagen, have been newly undervalued and are now rated 4 stars by Morningstar analysts. Freshpet has moved from a 4-star rating to a 5-star rating. The Morningstar US Market Index fell 0.01% over the past week, with 34% of stocks considered undervalued, 42% fairly valued, and 24% overvalued.

Four US-listed stocks, Keurig Dr Pepper (KDP), Ball (BALL), Hormel Foods (HRL), and Qiagen (QGEN), have been newly undervalued and are now rated 4 stars by Morningstar analysts. Freshpet (FRPT) has moved from a 4-star rating to a 5-star rating. The Morningstar US Market Index fell 0.01% over the past week, with 34% of stocks considered undervalued, 42% fairly valued, and 24% overvalued [1].

Keurig Dr Pepper, a nonalcoholic beverages company, has seen its stock price drop 17.21% over the past week. It is trading 17% below its fair value estimate of $35 per share, with an Uncertainty Rating of Medium. Ball, a packaging and containers company, has lost 2.03% over the past week, trading at a 12% discount to its fair value estimate of $60 per share, with an Uncertainty Rating of Medium. Hormel Foods, a packaged-foods company, is down 13.03% over the past week, trading 18% below its fair value estimate of $31 per share, with an Uncertainty Rating of Medium. Qiagen, a diagnostics and research firm, has climbed 6.51% over the past week, trading at a 13% discount to its fair value estimate of $53.49 per share, with an Uncertainty Rating of Medium [1].

Freshpet, a packaged-foods company, has dropped 10.86% over the past week, trading at a 47% discount to its fair value estimate of $105, with an Uncertainty Rating of High. This move reflects a significant discount to its intrinsic value, making it a compelling opportunity for value investors [2].

The market's recent volatility highlights the importance of thorough analysis and long-term perspective. While short-term market fluctuations can be challenging, the current valuations of these stocks suggest potential undervaluation and long-term growth opportunities. Investors should consider the fundamentals and potential risks before making investment decisions.

References:
[1] https://www.morningstar.com/stocks/5-new-4-star-stocks
[2] https://seekingalpha.com/news/4489845-qiagen-to-raise-750m-via-non-us-offering-of-convertible-bonds
[3] https://www.ainvest.com/news/freshpet-nasdaq-frpt-contrarian-buy-59-drop-investor-perspective-market-overreaction-fundamental-resilience-2509/